PIK3CD and T-cell non-Hodgkin lymphoma: In summary, while RV1001 predominantly targets the p110δ isoform, activity of other isoforms has been demonstrated as well [17], and some of the biologic activity of RV1001 in T-cell NHL may be due to inhibition of multiple isoforms at the plasma concentrations attained.